NDC 68516-4604
Alphanate
Antihemophilic Factor/von Willebrand Factor Complex (human)
Alphanate is a Intravenous Kit in the Plasma Derivative category. It is labeled and distributed by Grifols Usa, Llc. The primary component is .
| Product ID | 68516-4604_8ac02dd6-799a-4d48-965b-ed9a58a74b7f |
| NDC | 68516-4604 |
| Product Type | Plasma Derivative |
| Proprietary Name | Alphanate |
| Generic Name | Antihemophilic Factor/von Willebrand Factor Complex (human) |
| Dosage Form | Kit |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 1978-08-15 |
| Marketing End Date | 2020-03-31 |
| Marketing Category | BLA / BLA |
| Application Number | BLA102475 |
| Labeler Name | GRIFOLS USA, LLC |
| Active Ingredient Strength | 0 |
| NDC Exclude Flag | N |
Packaging
NDC 68516-4604-2
1 KIT in 1 CARTON (68516-4604-2) * 10 mL in 1 VIAL (68516-4608-2) * 10 mL in 1 VIAL, SINGLE-DOSE (63323-185-10)
| Marketing Start Date | 2007-01-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 68516-4604-2 [68516460402]
Alphanate KIT
| Marketing Category | BLA |
| Application Number | BLA102475 |
| Product Type | PLASMA DERIVATIVE |
| Billing Unit | EA |
| Marketing Start Date | 1978-08-15 |
| Marketing End Date | 2020-03-31 |
Drug Details
NDC Crossover Matching brand name "Alphanate" or generic name "Antihemophilic Factor/von Willebrand Factor Complex (human)"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 68516-4601 | Alphanate | Antihemophilic Factor/von Willebrand Factor Complex (Human) |
| 68516-4602 | Alphanate | Antihemophilic Factor/von Willebrand Factor Complex (Human) |
| 68516-4603 | Alphanate | Antihemophilic Factor/von Willebrand Factor Complex (Human) |
| 68516-4604 | Alphanate | Antihemophilic Factor/von Willebrand Factor Complex (Human) |
| 68516-4609 | Alphanate | Antihemophilic Factor/von Willebrand Factor Complex (Human) |
| 68516-4611 | Alphanate | Antihemophilic Factor/von Willebrand Factor Complex (Human) |
| 68516-4612 | Alphanate | Antihemophilic Factor/von Willebrand Factor Complex (Human) |
| 68516-4613 | Alphanate | Antihemophilic Factor/von Willebrand Factor Complex (Human) |
| 68516-4614 | Alphanate | Antihemophilic Factor/von Willebrand Factor Complex (Human) |
| 68516-4615 | Alphanate | Antihemophilic Factor/von Willebrand Factor Complex (Human) |
| 68516-4616 | Alphanate | Antihemophilic Factor/von Willebrand Factor Complex (Human) |
| 68516-4617 | Alphanate | Antihemophilic Factor/von Willebrand Factor Complex (Human) |
| 68516-4618 | Alphanate | Antihemophilic Factor/von Willebrand Factor Complex (Human) |
| 68516-4619 | Alphanate | Antihemophilic Factor/von Willebrand Factor Complex (Human) |
| 68516-4620 | Alphanate | Antihemophilic Factor/von Willebrand Factor Complex (Human) |
| 63833-615 | Humate-P | antihemophilic factor/von willebrand factor complex (human) |
| 63833-616 | Humate-P | antihemophilic factor/von willebrand factor complex (human) |
| 63833-617 | Humate-P | antihemophilic factor/von willebrand factor complex (human) |
Trademark Results [Alphanate]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 ALPHANATE 74475193 1964502 Live/Registered |
GRIFOLS SHARED SERVICES NORTH AMERICA, INC. 1993-12-28 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.